BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 29328473)

  • 1. Detection of high-grade neoplasia in air-dried cervical PAP smears by a microRNA-based classifier.
    Ivanov MK; Titov SE; Glushkov SA; Dzyubenko VV; Malek AV; Arkhangelskaya PA; Samsonov RB; Mikhetko AA; Bakhidze EV; Berlev IV; Kolesnikov NN
    Oncol Rep; 2018 Mar; 39(3):1099-1111. PubMed ID: 29328473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.
    Shen-Gunther J; Wang CM; Poage GM; Lin CL; Perez L; Banks NA; Huang TH
    Clin Epigenetics; 2016; 8(1):96. PubMed ID: 27651839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between micronucleus frequency and cervical intraepithelial neoplasia grade in Thinprep cytological test and its significance.
    Shi YH; Wang BW; Tuokan T; Li QZ; Zhang YJ
    Int J Clin Exp Pathol; 2015; 8(7):8426-32. PubMed ID: 26339413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can the careHPV test performed in mobile units replace cytology for screening in rural and remote areas?
    Lorenzi AT; Fregnani JH; Possati-Resende JC; Antoniazzi M; Scapulatempo-Neto C; Syrjänen S; Villa LL; Longatto-Filho A
    Cancer Cytopathol; 2016 Aug; 124(8):581-8. PubMed ID: 27070446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of p16INK4a immunocytochemistry with the HPV polymerase chain reaction in predicting high grade cervical squamous intraepithelial lesions.
    Indarti J; Fernando D
    Asian Pac J Cancer Prev; 2013; 14(9):4989-92. PubMed ID: 24175764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of the Pap Test: A Report of HPV-DNA Test-Negative High-Grade Squamous Intraepithelial Lesions of the Female Lower Genital Tract.
    Hui Y; Hansen K; Murthy J; Chau D; Sung CJ; Quddus MR
    Acta Cytol; 2016; 60(5):445-450. PubMed ID: 27578366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are vaginal swabs comparable to cervical smears for human papillomavirus DNA testing?
    Coorevits L; Traen A; Bingé L; Van Dorpe J; Praet M; Boelens J; Padalko E
    J Gynecol Oncol; 2018 Jan; 29(1):e8. PubMed ID: 29185266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate histopathologic follow-up of cervista and aptima high-risk HPV assays in women with LSIL cytology.
    Zhang H; Varma KR; Han M; Matsko J; Zhao C
    Cancer Cytopathol; 2018 Aug; 126(8):525-532. PubMed ID: 29797678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory.
    Ashman D; Zhang H; Li J; Austin M; Wang T; Pradhan D; Zhao C
    J Am Soc Cytopathol; 2020; 9(6):550-555. PubMed ID: 32475726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
    Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
    BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Cervical Lesions and Cancer in Air-Dried Cytologic Smears by Combined Analysis of mRNA and miRNA Expression Levels.
    Ivanov MK; Titov SE; Dzyubenko VV; Glushkov SA; Krasilnikov SE; Mansurova AS; Malek AV; Berlev IV; Prisyazhnaya TS; Kuleshova SV; Hodkevich AA; Lancuhaj YA; Dimitriadi TA; Agletdinov EF
    J Mol Diagn; 2021 May; 23(5):541-554. PubMed ID: 33662584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the New Independent States of the Former Soviet Union and the Latin American Screening study cohorts.
    Syrjänen K; Shabalova I; Naud P; Kozachenko V; Derchain S; Zakharchenko S; Roteli-Martins C; Nerovjna R; Longatto-Filho A; Kljukina L; Tatti S; Branovskaja M; Hammes LS; Branca M; Grunjberga V; Erzen M; Sarian LO; Juschenko A; Costa S; Podistov J; Syrjänen S;
    Int J Gynecol Cancer; 2009 Jul; 19(5):934-42. PubMed ID: 19574788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of visual inspection with acetic acid in detecting high-grade cervical intraepithelial neoplasia in pre- and post-menopausal Thai women with minor cervical cytological abnormalities.
    Poomtavorn Y; Suwannarurk K
    Asian Pac J Cancer Prev; 2015; 16(6):2327-31. PubMed ID: 25824759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
    Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
    Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies.
    Nieh S; Chen SF; Chu TY; Lai HC; Lin YS; Fu E; Gau CH
    Gynecol Oncol; 2005 Apr; 97(1):35-40. PubMed ID: 15790434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3.
    Wu T; Chen X; Zheng B; Li J; Xie F; Ding X; Zeng Z; Zhao C
    J Am Soc Cytopathol; 2019; 8(4):206-211. PubMed ID: 31272603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear.
    Molden T; Nygård JF; Kraus I; Karlsen F; Nygård M; Skare GB; Skomedal H; Thoresen SO; Hagmar B
    Int J Cancer; 2005 May; 114(6):973-6. PubMed ID: 15645423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of human papillomavirus in screening for cervical cancer and precancerous lesions.
    Wang JL; Yang YZ; Dong WW; Sun J; Tao HT; Li RX; Hu Y
    Asian Pac J Cancer Prev; 2013; 14(5):2979-82. PubMed ID: 23803065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness.
    Kaufman RH; Adam E; Icenogle J; Reeves WC
    Am J Obstet Gynecol; 1997 Oct; 177(4):930-6. PubMed ID: 9369847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.